1-224967434-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001367479.1(DNAH14):c.502C>T(p.Pro168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00035 in 1,534,062 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001367479.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH14 | NM_001367479.1 | c.502C>T | p.Pro168Ser | missense_variant | 6/86 | ENST00000682510.1 | NP_001354408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH14 | ENST00000682510.1 | c.502C>T | p.Pro168Ser | missense_variant | 6/86 | NM_001367479.1 | ENSP00000508305 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000239 AC: 36AN: 150770Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000311 AC: 61AN: 196060Hom.: 0 AF XY: 0.000287 AC XY: 31AN XY: 108128
GnomAD4 exome AF: 0.000362 AC: 501AN: 1383292Hom.: 1 Cov.: 31 AF XY: 0.000338 AC XY: 232AN XY: 686592
GnomAD4 genome AF: 0.000239 AC: 36AN: 150770Hom.: 0 Cov.: 32 AF XY: 0.000218 AC XY: 16AN XY: 73522
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.502C>T (p.P168S) alteration is located in exon 6 (coding exon 5) of the DNAH14 gene. This alteration results from a C to T substitution at nucleotide position 502, causing the proline (P) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Axonemal dynein, but no disease association and no suspicious second variant - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at